JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 4, NUMBER 4, FALL 2003

Similar documents
Reference Photon Dosimetry Data for the Siemens Primus Linear Accelerator: Preliminary Results for Depth Dose and Output Factor

INTRODUCTION. Material and Methods

AAPM s TG 51 Protocol for Clinical Reference Dosimetry of High-Energy Photon and Electron Beams

Problems and Shortcomings of the RPC Remote Monitoring Program of Institutions Dosimetry Data

On the impact of ICRU report 90 recommendations on k Q factors for high-energy photon beams

An Independent Audit and Analysis of Small Field Dosimetry Quality Assurance. David Followill IROC Houston QA Center

TLD as a tool for remote verification of output for radiotherapy beams: 25 years of experience

An anthropomorphic head phantom with a BANG polymer gel insert for dosimetric evaluation of IMRT treatment delivery

Assessment of Dosimetric Functions of An Equinox 100 Telecobalt Machine

PMP. Use of Cylindrical Chambers as Substitutes for Parallel- Plate Chambers in Low-Energy Electron Dosimetry. Original Article.

Limits of Precision and Accuracy of Radiation Delivery Systems

Data Collected During Audits for Clinical Trials. July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff

Assessment of a three-dimensional (3D) water scanning system for beam commissioning and measurements on a helical tomotherapy unit

DOSIMETRIC COMPARISION FOR RADIATION QUALITY IN HIGH ENERGY PHOTON BEAMS

Dosimetric characterization of surface applicators for use with the Xoft ebx system

Implantable MOSFET dosimeter response to 192 Ir HDR radiation

D DAVID PUBLISHING. Uncertainties of in vivo Dosimetry Using Semiconductors. I. Introduction. 2. Methodology

QA for Clinical Dosimetry with Emphasis on Clinical Trials

Accuracy Requirements and Uncertainty Considerations in Radiation Therapy

The Accuracy of 3-D Inhomogeneity Photon Algorithms in Commercial Treatment Planning Systems using a Heterogeneous Lung Phantom

Plan-Specific Correction Factors for Small- Volume Ion Chamber Dosimetry in Modulated Treatments on a Varian Trilogy

S. Derreumaux (IRSN) Accidents in radiation therapy in France: causes, consequences and lessons learned

IMRT QA: Point Dose Measurements or 2D Array?

The RPC s Evaluation of Advanced Technologies. AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff

IMRT QUESTIONNAIRE. Address: Physicist: Research Associate: Dosimetrist: Responsible Radiation Oncologist(s)

Basic dosimetric data for treatment planning system

Level of Accuracy Practically Achievable in Radiation Therapy. David Followill and RPC staff August 6, 2013

Calibration of dosimeters for small mega voltage photon fields at ARPANSA

Implementing New Technologies for Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy

TREATMENT PLANNING: CLINICAL ELECTRONS John A. Antolak, Ph.D. Prepared for the AAPM Therapy Physics Review Course Austin, TX July 19 20, 2014 PURPOSE

Comparative Study of Absorbed Doses in Different Phantom Materials and Fabrication of a Suitable Phantom

IN VIVO DOSIMETRY MEASUREMENTS FOR BREAST RADIATION TREATMENTS

Verification of Relative Output Factor (ROF) Measurement for Radiosurgery Small Photon Beams

Semiflex 3D. Always perfectly oriented. 3D Thimble Ionization Chamber for Relative and Absolute Dosimetry

IMRT point dose measurements with a diamond detector

Out-of-field doses of CyberKnife in stereotactic radiotherapy of prostate cancer patients

EXPERIMENTAL RESULTS IN PERCENTAGE DEPTH DOSE (PDD) DETERMINATION AT THE EXTENDED DISTANCES *

Beam Quality Effects in Nonstandard Fields of the Varian TrueBeam

Standard calibration of ionization chambers used in radiation therapy dosimetry and evaluation of uncertainties

What Can Go Wrong in Radiation Treatment: Data from the RPC. Geoffrey S. Ibbott, Ph.D. and RPC Staff

Ion recombination corrections of ionization chambers in flattening filter-free photon radiation

Can we hit the target? Can we put the dose where we want it? Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy

Effect of scattered radiation in the total body irradiation technique: evaluation of the spoiler and wall dose component in the depthdose distribution

Quality assurance in external radiotherapy

IAEA-CN THE ESTRO-EQUAL RESULTS FOR PHOTON AND ELECTRON BEAMS CHECKS IN EUROPEAN RADIOTHERAPY BEAMS*

Semiflex 3D. Always perfectly oriented. 3D Thimble Ionization Chamber for Relative and Absolute Dosimetry

Multilayer Gafchromic film detectors for breast skin dose determination in vivo

Patient dosimetry for total body irradiation using single-use MOSFET detectors

Independent corroboration of monitor unit calculations performed by a 3D computerized planning system

A new geometric and mechanical verification device for medical LINACs

SRS/SBRT Errors and Causes

Mania Aspradakis John Byrne Hugo Palmans John Conway Jim Warrington Karen Rosser Simon Duane

4 Essentials of CK Physics 8/2/2012. SRS using the CyberKnife. Disclaimer/Conflict of Interest

Intensity Modulated Radiation Therapy: Dosimetric Aspects & Commissioning Strategies

Assessment of variation of wedge factor with depth, field size and SSD for Neptun 10PC Linac in Mashhad Imam Reza Hospital

Application of MCNP4C Monte Carlo code in radiation dosimetry in heterogeneous phantom

Topics covered 7/21/2014. Radiation Dosimetry for Proton Therapy

Anthropomorphic breast phantoms for quality assurance and dose verification

STEREOTACTIC DOSE VERIFICATION PHANTOM VERSATILE STEREOTACTIC QA PHANTOMS

Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCT

A Dosimetric study of different MLC expansion aperture For the radiotherapy of pancreas cancer

Disclosure. Outline. Machine Overview. I have received honoraria from Accuray in the past. I have had travel expenses paid by Accuray in the past.

Comparison of dosimetry parameters of two commercially available Iodine brachytherapy seeds using Monte Carlo calculations

How accurately can we measure dose clinically? Accurate clinical dosimetry. Dosimetric accuracy requirement

ABSTRACTS FOR RADIOTHERAPY STANDARDS USERS MEETING. 5 th June 2007

RPC s Credentialing Programs for Clinical Trials

LONG TERM STABILITY OF THE PERFORMANCE OF A CLINICAL LINEAR ACCELERATOR AND Z-SCORE ASSESSEMENT FOR ABSORBED DOSE TO WATER QUANTITY

Abstract: A National Project for the in-vivo dosimetry in radiotherapy: first results

The influence of field size on stopping-power ratios in- and out-of-field: quantitative data for the BrainLAB m3 micro-multileaf collimator

AAPM Administrative Policy: Joint AAPM/IROC Houston Registry of Brachytherapy Sources Complying with AAPM Dosimetric Prerequisites

Small field diode dosimetry

Presented by: Rebecca M. Howell PhD, DABR, FAAPM. Results from Voluntary Independent External Peer Review of Beam Output

Eric E. Klein, Ph.D. Chair of TG-142

Introduction. Measurement of Secondary Radiation for Electron and Proton Accelerators. Introduction - Photons. Introduction - Neutrons.

ROPES eye plaque dosimetry: commissioning and verification of an ophthalmic brachytherapy treatment planning system

Small Field Dosimetry: Overview of AAPM TG-155 and the IAEA-AAPM Code of Practice (Therapy)

The Journey of Cyberknife Commissioning

EORTC Member Facility Questionnaire

Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom

Film-based dose validation of Monte Carlo algorithm for Cyberknife system with a CIRS thorax phantom

Applications of Monte Carlo simulations to radiation dosimetry

Calibration of Radiation Instruments Used in Radiation Protection and Radiotherapy in Malaysia

Application(s) of Alanine

IGRT1 technologies. Paweł Kukołowicz Warsaw, Poland

Transition to Heterogeneity Corrections. Why have accurate dose algorithms?

Comparison of microlion liquid filled ionisation chamber with Semiflex and Pinpoint air filled chambers

Inhomogeneity correction and the analytic anisotropic algorithm

RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy

Measurement of Dose to Implanted Cardiac Devices in Radiotherapy Patients

Dose Homogeneity of the Total Body Irradiation in vivo and in vitro confirmed with Thermoluminescent Dosimeter

Diode calibration for dose determination in total body irradiation

SBRT Credentialing: Understanding the Process from Inquiry to Approval

Computed tomography Acceptance testing and dose measurements

DOSE MEASUREMENTS IN TELETHERAPY USING THERMOLUMINESCENT DOSIMETERS

Study of a spherical phantom for Gamma knife dosimetry

How accurately can we measure dose clinically? Dosimetric accuracy requirement. Accurate Clinical dosimetry. Part I: Fundamentals and Issues

Traceability and absorbed dose standards for small fields, IMRT and helical tomotherapy

The clinical use of OSLD

Diode Dosimetric Characteristics Assessment for In-Vivo Dosimetry in Radiotherapy Treatment

Transcription:

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, VOLUME 4, NUMBER 4, FALL 2003 Reference photon dosimetry data: A preliminary study of in-air off-axis factor, percentage depth dose, and output factor of the Siemens Primus linear accelerator S. H. Cho* and G. S. Ibbott Department of Radiation Physics, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 547, Houston, Texas 77030 Received 10 April 2003; accepted 21 August 2003 The dosimetric characteristics for modern computer-controlled linear accelerators with the same make, model, and nominal energy are known to be very similar, as long as the machines are unaltered from the manufacturer s original specifications. In this preliminary study, a quantitative investigation of the similarity in the basic photon dosimetry data from the Siemens Primus linear accelerators at eight different institutions is reported. The output factor, percentage depth dose, and in-air off-axis factor OAF for the 6 and 18 MV photon beams measured or verified by the Radiological Physics Center RPC were analyzed. The RPCmeasured output factors varied by less than about 2% for each field size. The difference between the maximum and minimum RPC-verified values at each depth was less than about 3%. The difference between the maximum and minimum RPC-measured in-air OAF was no more than 4% at all off-axis distances considered in this study. These results strongly suggest that it is feasible to establish a reference photon dosimetry data set for each make, model, and nominal energy, universally applicable to those machines unaltered from the manufacturers original specifications, within a clinically acceptable tolerance e.g., 2%). 2003 American College of Medical Physics. DOI: 10.1120/1.1617191 PACS number s : 87.53. j, 87.66. a Key words: Primus linear accelerators; output factor; off-axis factor; percentage depth dose; reference photon dosimetry data INTRODUCTION Due to improved machining techniques during manufacturing and the use of computers during operation, the construction and dosimetric characteristics of modern computer-controlled linear accelerators are generally very reproducible. 1 This observation seems to be valid at least for photon beams whose dosimetric characteristics are generally less sensitive to minute changes in the machine structure than those for electron beams. In fact, matching of dosimetric characteristics among machines is very common. As more machines are being matched, the question arises of how similar are the machines of the same make, model, and nominal energy, across the institutions, in terms of their dosimetric characteristics. Certainly, the benefits from quantifying such similarity would be significant and will be discussed in detail in this article. One way to perform a systematic and quantitative analysis of the similarity among machines is to investigate some standard behavior among the basic dosimetry data that have been acquired by the Radiological Physics Center RPC at M.D. Anderson Cancer Center, through its on-site dosimetry review program. To demonstrate the efficacy and validity of this approach, a preliminary study was conducted by analyzing three important photon dosimetry data sets, output factor, in-air off-axis factor, and percentage depth dose, for one of the recent model linear accelerators, the Siemens Primus first released in 1997. 300 1526-9914Õ2003Õ4 4 Õ300Õ7Õ$17.00 2003 Am. Coll. Med. Phys. 300

301 S. H. Cho and G. S. Ibbott: Reference photon dosimetry data: A preliminary... 301 TABLE I. Makes and models of the chambers used. Ion chamber Wall material Cavity radius cm NEL 2571 Graphite 0.315 PTW N23333 PMMA 0.305 PTW N30001 PMMA 0.305 Exradin A-12 C-552 0.305 METHODS AND MATERIALS Definitions The definitions of variables and dosimetric quantities used in this study are provided below. Note the following notations are used through out this article, whenever possible: rdg: the electrometer reading following a measurement with an ion chamber. CAX: the central axis of a beam. SSD: the source-to-surface distance for a beam. The nominal SSD is 100 cm. FS: the field size of a beam, defined at the nominal SSD. RFS: the reference field size. Note RFS is normally a 10 cm 10 cm field for photon beams. d max : the depth along the CAX at which the absorbed dose in medium is maximum for a given beam. d ref : the reference depth along the CAX for measurements in a phantom. Fractional Depth Dose FDD : FDD (rdg at depth on CAX for FS, SSD/rdg at d max on CAX for FS, SSD) Percentage Depth Dose : FDD 100 Output Factor OF : OF (rdg at d ref fo FS)/(FDD at d ref for FS) / (rdg at d ref for RFS)/(FDD at d ref for RFS) Off-Axis Factor OAF : OAF rdg at off-axis distance/rdg at CAX Note OAF is usually defined for the largest field size available e.g., 40 cm 40 cm for photon beams, at a depth in a phantom or at the isocenter in air. Measurements For the determination of the output factor and depth dose, measurements were performed with Farmer-type cylindrical chambers in a 30 40 40 cm 3 water phantom. The makes and models of the chambers used are given in Table I. Identical electrometers Keithley model 602 were used for measurements. For nonwaterproof chambers, a waterproofing sleeve with a 1 mm thick polymethylmethacrylate PMMA wall was used. 2 Photon beams from the Siemens Primus accelerators were normally incident on the phantom surface at an SSD of 100 cm. The ion chamber readings for depth doses were taken at d max, 5, 10, 15, and 20 cm depths for 6 cm 6 cm, 10 cm 10 cm, and 20 cm 20 cm field sizes. The ion chamber readings for output factors were obtained at a reference depth (d ref ) of 10 cm for the field sizes, 6 cm 6 cm, 10 cm 10 cm, 15 cm 15 cm, 20 cm 20 cm, and 30 cm 30 cm. The RPC s depths of measurements incorporated a shift to the effective point of measurement following the recommendation from the TG-51 protocol i.e., 0.6 times the radius of the chamber cavity upstream from the chamber axis. 2 At the time of this study, participating institutions measured their data without this shift, however, an appropriate conversion was applied to the RPC-measured data to enable comparison at the

302 S. H. Cho and G. S. Ibbott: Reference photon dosimetry data: A preliminary... 302 depths reported by the institution i.e., depths without any shift in the chamber positioning. Consequently, the final results i.e., and output factor presented in this article represent measurements at depths with no shift in the chamber positioning. For the determination of the in-air off-axis factor, measurements were performed with either NEL or PTW chambers listed in Table I, at an SAD of 100 cm, with an appropriate plastic buildup cap for the photon energy in question. A 40 cm 40 cm field size was chosen for in-air measurements. Measurements were made at 5, 10, and 15 cm off-axis distances from the CAX. Data analysis Eight sets of data, one from each of eight different institutions visited by the RPC were obtained for the 6 and 18 MV photon beams from the Siemens Primus linear accelerators. The dates of first clinical use for these eight machines were evenly spread out over a 3 yr period. Therefore, there was very little correlation between these Primus accelerators, other than the fact that they were unaltered from the manufacturer s original specifications. The institutions s were verified by the RPC at selected depths i.e., 5, 10, 15, and 20 cm. The agreement between RPC-measured and institution s data was better than 1% for the majority ( 90%) of the data points and no worse than 2% in any case. Although the data for a 30 cm 30 cm field size were not verified by the RPC, a similar agreement was assumed and the data for this field size were included in the analysis. As a result, the final averages as presented in this study were based on the institutions data to provide a smooth and comprehensive data set over a wide range of depths and field sizes. The RPC does not routinely make measurements in the buildup region; therefore, no data for this region are presented in this study. All of the 6 MV data were normalized at a depth of 1.5 cm, which is nominally the depth of maximum dose (d max ) for the 6 MV photon beam, regardless of the field size. On the other hand, for the 18 MV photon beam, the institutions data were normalized at different depths depending on the field size. No renormalization of the institution data was attempted during the analysis; instead, the data were accepted as presented by the institutions. A nominal d max for the 18 MV photon beam is 3.5 cm for a 10 cm 10 cm field size and the institutions investigated in this study chose a depth between 3.0 and 3.5 cm as their d max depth for this field size. In any case, the impact from this uncertainty in the depth of normalization is believed to be insignificant, because of a relatively large plateau in the for the 18 MV photon beam. The analysis of the photon output factors was based on the RPC-measured output factors only, because the RPC-measured data consistently covered a wide range of field sizes, providing a reasonable characterization of the field size dependence of photon output factors. The agreement between the RPC-measured and institution s data was as good as that for the s. Similar to other dosimetry data, eight sets of the RPC-measured in-air off-axis factors were statistically analyzed. Although the beam profiles measured in water are more clinically relevant, in-air beam profiles could be very helpful in determining the characteristics of the electron pencil beam incident on the target in the head of a linear accelerator 3 and, therefore, were included in this study. RESULTS The results are presented here as tables so that the data can be easily compared with clinical data. All results are the averages over eight sets of either the RPC-measured or the RPC-verified institution data. Output factor Tables II and III show the results of the RPC-measured output factors for the 6 and 18 MV photon beams, respectively. In addition to the standard deviation, the ratios between the maximum and minimum data are also presented. As seen in these tables, the presented average values are

303 S. H. Cho and G. S. Ibbott: Reference photon dosimetry data: A preliminary... 303 TABLE II. The RPC-measured output factors for the 6 MV photon beam from Siemens Primus accelerators. Note the averages were obtained from eight sets of measured data. Field size Average OF Max/min 6 6 0.954 1.015 0.48 10 10 1.000 - - 15 15 1.034 1.012 0.41 20 20 1.053 1.014 0.45 30 30 1.075 1.020 0.65 statistically very tight with a maximum standard deviation of about 0.7% or max/min ratios less than 1.02, suggesting a possibility for them to be used as reference or benchmark data for the Primus linear accelerators. Percentage depth dose The results from the analysis of the in water are presented in Tables IV and V. Note that each depth indicated in these tables is considered to be the depth without any shift in chamber positioning, as explained earlier. As shown in the tables, the results are again statistically very tight with a maximum standard deviation of about 1.4% or max/min ratio always less than 1.03. Consequently, the data presented here could be used as reference data for the Primus accelerators as well. In-air off-axis factor The results from the analysis of in-air OAF are presented in Tables VI and VII. As shown in these tables, the difference between the maximum and minimum values at each off-axis point was no more than 4%. The largest standard deviation associated with the data was about 1.3% indicating that in-air OAF data presented here could be used as reference data for the Primus accelerators. Note the results presented in these tables in-air OAF and, therefore, may be different from in-water OAF. DISCUSSION This study shows that some standard behavior among linear accelerators with the same make, model, and nominal energy can be quantitatively investigated. The results strongly suggest that each photon dosimetry characteristic studied i.e.,, output factor, in-air OAF could be predicted within a statistical uncertainty comparable to experimental uncertainty. Consequently, it appears possible to establish a basic photon dosimetry data set for each make, model, and nominal energy, universally applicable to those machines unaltered from the manufacturers original speci- TABLE III. The RPC-measured output factors for the 18 MV photon beam from Siemens Primus accelerators. Note the averages were obtained from eight sets of measured data. Field size Average of Max/min 6 6 0.952 1.006 0.22 10 10 1.000 - - 15 15 1.036 1.021 0.69 20 20 1.059 1.018 0.59 30 30 1.080 1.015 0.48

304 S. H. Cho and G. S. Ibbott: Reference photon dosimetry data: A preliminary... 304 TABLE IV. table for the 6 MV photon beam from Siemens Primus accelerators. Note: i the averages were obtained from 8 sets of the RPC-verified institution data; ii max/min values for each average in this table are less than 1.03. Depth cm 6cm 6cm 10 cm 10 cm 20 cm 20 cm 30 cm 30 cm 1.5 100.0-100.0-100.0-100.0-2 99.3 0.30 99.1 0.29 99.1 0.21 98.8 0.26 3 95.0 0.24 95.2 0.42 95.5 0.32 95.5 0.37 4 90.3 0.43 91.1 0.45 91.7 0.34 91.8 0.48 5 85.8 0.34 86.9 0.47 88.3 0.42 88.5 0.41 6 81.2 0.21 82.7 0.50 84.3 0.39 85.1 0.40 7 76.8 0.24 78.7 0.38 80.7 0.49 81.6 0.48 8 72.5 0.42 74.6 0.34 77.1 0.52 78.3 0.46 9 68.4 0.54 70.9 0.49 73.6 0.59 74.8 0.79 10 64.8 0.45 67.3 0.61 70.5 0.56 71.8 0.68 15 48.3 0.72 51.3 0.69 55.4 0.76 57.4 0.66 20 36.1 0.84 38.9 0.93 43.2 0.96 45.3 0.78 25 27.0 0.91 29.3 0.67 33.5 0.60 35.5 0.95 30 20.4 0.85 22.4 1.17 26.0 1.16 28.0 0.55 fications, within a clinically acceptable tolerance e.g., 2%). If such data sets, referred to as reference photon dosimetry data should become available, some potential benefits for the practice of medical physics will be easily seen. Clearly, the most significant benefit of reference photon dosimetry data would be the ease of the beam commissioning process, especially for photon beams. Note that it is unclear at this time whether or not the approach presented in this study can be successfully applied to electron beams. Normally, medical physicists have to spend several weeks taking beam data during the commissioning of a new machine. Once the reference photon dosimetry data become available, it is conceivable that medical physicists may perform a spot check against a reference photon dosimetry data set for the machine in question, instead of very time-consuming data taking. Also, it would be possible to envision that generic photon beam models could be constructed using the reference data for the application of convolution or Monte Carlo-based algorithms so that the commissioning of treatment planning systems could become more standardized and straightforward. At this time, however, it is uncertain whether or not this kind of practice might be allowed in reality, due to various reasons such as possible regulatory concerns. Furthermore, a consensus TABLE V. table for the 18 MV photon beam from Siemens Primus accelerators. Note: i the averages were obtained from eight sets of the RPC-verified institution data; ii Note max/min values for each average in this table are less than 1.03; iii A typical d max ata10cm 10 cm field size for 18 MV photon beam is 3.5 cm. Depth cm 6cm 6cm 10 cm 10 cm 20 cm 20 cm 30 cm 30 cm d max 100.0-100.0-100.0-100.0-4 98.9 0.23 98.8 0.22 98.3 0.34 97.5 0.95 5 95.8 0.49 95.7 0.42 94.9 0.52 94.6 0.49 6 91.8 0.50 92.0 0.39 91.7 0.53 91.2 0.81 7 88.0 0.48 88.3 0.45 88.3 0.47 88.0 0.75 8 84.3 0.57 84.9 0.46 85.1 0.49 84.9 0.73 9 80.7 0.55 81.5 0.44 81.9 0.39 81.9 0.72 10 77.3 0.54 78.1 0.39 78.8 0.58 79.1 0.72 15 61.9 0.65 63.4 0.51 64.9 0.61 65.6 0.59 20 49.6 0.67 51.2 0.57 53.4 0.80 54.4 0.49 25 39.8 0.96 41.5 0.92 43.8 0.83 44.8 1.11 30 32.1 1.12 33.7 1.12 35.9 1.38 37.1 0.61

305 S. H. Cho and G. S. Ibbott: Reference photon dosimetry data: A preliminary... 305 TABLE VI. In-air off-axis factors for the 6 MV photon beam from Siemens Primus accelerators. Note: i The averages were obtained from 8 sets of the RPC-measured data; ii The presented values may be different from in-water OAF. Off-axis distance cm Average OAF Max/min 5 1.042 1.014 0.42 10 1.058 1.024 0.86 15 1.075 1.037 1.30 among medical physicists must be reached in order to allow such practice, even after wellestablished reference data become available. Nevertheless, there would be no question about the value of the reference data, especially as a powerful tool for checking the integrity of commissioned data and corresponding beam models. Another important benefit from the reference photon dosimetry data could be seen for multiinstitutional quality assurance QA monitoring programs such as the Radiological Physics Center RPC. A previous study 4 conducted at the RPC suggested that the integrity of clinical dosimetry data as used at each institution participating in national clinical trials could be reviewed by comparing the institutions data against the RPC s standard data, without visiting each participant to measure its dosimetry data. The major difficulties in performing such a review were the lack of the RPC s standard data for certain dosimerty data e.g., wedge factor and some anomalies shown in the RPC s standard data for older machines and electron beams. These difficulties need to be overcome in order for the RPC to successfully utilize this approach. Currently, a major study on this subject is underway at the RPC by applying the Monte Carlo method and new measurement techniques e.g., ion chamber array, MOSFET, etc.. Electron beams are currently being excluded from this study, because it is still questionable whether or not the institutions electron dosimetry data can be predicted within an acceptable uncertainty e.g., 2%) even by the Monte Carlo method. 5 In any case, the results i.e., the reference photon dosimetry data for most common machines will be presented in the future through peer-reviewed publications as well as the RPC web site http://rpc.mdanderson.org, as they become available. CONCLUSIONS The current preliminary study shows that the similarity in the basic photon dosimetry data among linear accelerators with the same make, model, and nominal energy can be quantitatively investigated. A statistical analysis was performed with the basic photon dosimetry data from the Siemens Primus linear accelerators at eight different institutions. The dosimetry data included in the analysis were the output factor, percentage depth dose, and in-air off-axis factor OAF for the 6 and 18 MV photon beams, which were measured or verified by the Radiological Physics Center RPC through its on-site dosimetry review program. The RPC-measured output factors varied by less than about 2% for each field size. The difference between the maximum and minimum RPC-verified values at each depth was less than about 3%. The difference between the maximum and minimum RPC-measured in-air OAF was no more than 4% at all off-axis distances considered in this study. These results strongly suggest that it is feasible to establish a TABLE VII. In-air off-axis factors for the 18 MV photon beam from Siemens Primus accelerators. Note: i The averages were obtained from 8 sets of the RPC-measured data; ii The presented values may be different from in-water OAF. Off-axis distance cm Average OAF Max/min 5 1.054 1.033 1.01 10 1.060 1.035 1.12 15 1.063 1.040 1.32

306 S. H. Cho and G. S. Ibbott: Reference photon dosimetry data: A preliminary... 306 reference photon dosimetry data set for each make, model, and nominal energy, universally applicable to those machines unaltered from the manufacturers original specifications, within a clinically acceptable tolerance e.g., 2%). ACKNOWLEDGMENTS This investigation was supported by Public Health Service Grant No. CA 10953 awarded by the National Cancer Institute, Department of Health and Human Services. The authors acknowledge the contribution of other physicists at the RPC to the data used in this study. Also, the authors would like to thank Mr. Paul Holguin at the RPC for his help in retrieving the measured data from the RPC database. *Email address: scho@mdanderson.org Email address: gibbott@mdanderson.org 1 R. J. Watts, Comparative measurements on a series of accelerators by the same vendor, Med. Phys. 26, 2581 2685 1999. 2 P. R. Almond, P. J. Biggs, B. M. Coursey, W. F. Hanson, M. S. Huq, R. Nath, and D. W. O. Rogers, AAPM s TG-51 protocol for clinical reference dosimetry of high-energy photon and electron beams, Med. Phys. 26, 1847 1870 1999. 3 D. Sheikh-Bagheri and D. W. O. Rogers, Sensitivity of megavoltage photon beam Monte Carlo simulations to electron beam and other parameters, Med. Phys. 29, 379 390 2002. 4 J. A. BenComo, D. S. Followill, S. H. Cho, P. Balter, R. C. Tailor, J. R. Lowenstein, N. Hernandez, and W. F. Hanson, Comparison of on-site and off-site evaluations of dosimetry data, Proceedings of the 2000 World Congress on Medical Physics and Biomedical Engineering, TU-FXH-45 IEEE, New York, 2000. 5 J. A. Antolak, M. R. Bieda, and K. R. Hogstrom, Using Monte Carlo methods to commission electron beams: A feasibility study, Med. Phys. 29, 771 786 2002.